No results for ‘’
Sree Rayalaseema Hi-Strength Hypo Ltd
NSE: SRHHYPOLTD BSE: 532842
₹523.80
(1.30%)
Mon, 14 Sept 2026, 10:25 pm
Market Cap (in Cr)896.09
PE Ratio9.77
Dividend0.57
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
- FAQs
Sree Rayalaseema Hi-Strength Hypo Analysis
dividend
Pros
- Dividends paid are well covered by earnings (5.6x coverage).
- Sree Rayalaseema Hi-Strength Hypo's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Cons
- Dividend payments have increased, but Sree Rayalaseema Hi-Strength Hypo only paid a dividend in the past 9 years.
- Sree Rayalaseema Hi-Strength Hypo has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Sree Rayalaseema Hi-Strength Hypo's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
Pros
- Sree Rayalaseema Hi-Strength Hypo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Sree Rayalaseema Hi-Strength Hypo is profitable, therefore cash runway is not a concern.
- Sree Rayalaseema Hi-Strength Hypo is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (246.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 6.5x debt.
- Sree Rayalaseema Hi-Strength Hypo's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (49.3% vs 10% today).
- Interest payments on debt are well covered by earnings (EBIT is 9.3x coverage).
- Sree Rayalaseema Hi-Strength Hypo's level of debt (10%) compared to net worth is satisfactory (less than 40%).
Cons
- High level of physical assets or inventory.
management
Pros
- The tenure for the Sree Rayalaseema Hi-Strength Hypo board of directors is about average.
- Tumbalam's compensation has been consistent with company performance over the past year, both up more than 20%.
Cons
- Tumbalam's remuneration is higher than average for companies of similar size in India.
misc
Pros
Cons
- Sree Rayalaseema Hi-Strength Hypo is not covered by any analysts.
- Sree Rayalaseema Hi-Strength Hypo has significant price volatility in the past 3 months.
past
Pros
- Sree Rayalaseema Hi-Strength Hypo's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
- Sree Rayalaseema Hi-Strength Hypo has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Cons
- Sree Rayalaseema Hi-Strength Hypo's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Sree Rayalaseema Hi-Strength Hypo used its assets less efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Sree Rayalaseema Hi-Strength Hypo has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Sree Rayalaseema Hi-Strength Hypo's 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
value
Pros
- Sree Rayalaseema Hi-Strength Hypo's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Sree Rayalaseema Hi-Strength Hypo's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Sree Rayalaseema Hi-Strength Hypo is good value based on assets compared to the IN Chemicals industry average.
- Sree Rayalaseema Hi-Strength Hypo is good value based on earnings compared to the IN Chemicals industry average.
- Sree Rayalaseema Hi-Strength Hypo is good value based on earnings compared to the India market.
- 532842 matched the India Market (-14.5%) over the past year.
- BSE:532842 is up 8.1% outperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:532842 is up 8.1% along with the India market (8%) over the past month.
Cons
- 532842 underperformed the Chemicals industry which returned 2.2% over the past year.